4//SEC Filing
Matsuda Masaru 4
Accession 0001787306-25-000017
CIK 0001787306other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:01 PM ET
Size
6.3 KB
Accession
0001787306-25-000017
Insider Transaction Report
Form 4
Matsuda Masaru
See Remarks
Transactions
- Sale
Common Stock
2025-02-03$12.70/sh−8,338$105,893→ 178,692 total
Footnotes (3)
- [F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"), granted on January 12, 2024, in which 25% of the RSUs vest annually on February 1, (the "Vesting Commencement Date"), of each year beginning on February 1, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $12.545 to $13.0096, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Reflects the adjusted total which includes the acquisition of 4,000 shares and 1,657 shares under the Company's Employee Stock Purchase Plan on May 31, 2024 and November 30, 2024, respectively, which transactions were exempt from Section 16(a) and (b) and were erroneously reported as non-exempt purchases in the Reporting Person's Form 4 filed on December 3, 2024.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001798679
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:01 PM ET
- Size
- 6.3 KB